Table 1 Clinical characteristics by presence of severe small artery intimal thickening
Variables | Total (n = 122) | mild SA-IT index (Q1–Q3, n = 86) | severe SA-IT index (Q4, n = 36) | P value |
---|---|---|---|---|
Age (year) | 47 (36–61) | 41 (29–55) | 62 (57–67) | <0.001 |
Men (%) | 65 (47) | 47 (55) | 18 (50) | 0.64 |
BMI (kg/m2) | 24 (21–26) | 23 (21–26) | 24 (22–27) | 0.150 |
SBP (mmHg) | 124 (112–135) | 122 (110–133) | 130 (117–143) | 0.016 |
DBP (mmHg) | 76 (66–82) | 74 (68–83) | 77 (65–82) | 0.89 |
MAP (mmHg) | 97 (87–107) | 95 (86–104) | 101 (97–110) | 0.002 |
PP (mmHg) | 48 (42–58) | 48 (40–55) | 54 (46–74) | 0.003 |
Current smoking (%) | 20 (16) | 15 (17) | 5 (14) | 0.63 |
eGFR (mL/min/1.73 m2) | 62 (45–88) | 71 (49–97) | 54 (38–67) | 0.004 |
Proteinuria (g/g Cr) | 0.9 (0.4–2.5) | 0.8 (0.4–2.2) | 1.0 (0.5–3.0) | 0.39 |
HbA1c (%) | 5.5 (5.3–5.8) | 5.4 (5.1–5.7) | 5.8 (5.5–6.3) | <0.001 |
Total cholesterol (mmol/L) | 5.1 (4.3–6.4) | 5.1 (4.3–6.3) | 5.4 (4.9–6.6) | 0.171 |
Triglyceride (mmol/L) | 1.6 (1.1–2.5) | 1.6 (1.0–2.4) | 1.7 (1.3–3.1) | 0.23 |
HDL-cholesterol (mmol/L) | 1.4 (1.2–1.7) | 1.4 (1.2–1.7) | 1.3 (1.1–1.6) | 0.38 |
LDL-cholesterol (mmol/L) | 2.9 (2.2–3.6) | 2.7 (2.1–3.6) | 3.1 (2.6–3.7) | 0.173 |
Hypertension (%) | 71 (58) | 44 (51) | 27 (75) | 0.015 |
Diabetes mellitus (%) | 12 (9) | 5 (6) | 7 (19) | 0.021 |
Dyslipidemia (%) | 82 (67) | 54 (63) | 28 (78) | 0.108 |
baPWV (m/s) | 13.7 (12.2–15.8) | 12.9 (11.5–15.2) | 15.3 (13.7–17.3) | <0.001 |
ABI | 1.16 (1.09–1.22) | 1.15 (1.09–1.21) | 1.20 (1.11–1.25) | 0.011 |
SA-IT index | 1.2 (0.5–2.0) | 1.0 (0.3–1.3) | 2.2 (2.0–2.7) | <0.001 |
Antihypertensive agents (%) | 66 (54) | 42 (49) | 24 (67) | 0.072 |
RAAS-I (%) | 58 (48) | 37 (43) | 21 (58) | 0.123 |
Statins (%) | 9 (7) | 5 (6) | 4 (11) | 0.31 |
Hypoglycemic agents (%) | 9 (7) | 5 (6) | 4 (11) | 0.31 |
Oral corticosteroids (%) | 14 (11) | 11 (13) | 3 (8) | 0.48 |
Calcineurin inhibitors (%) | 7 (6) | 5 (6) | 2 (6) | 0.96 |